LEE PHARMACEUTICALS FIRST QUARTER SALES DROP 29.9%
This article was originally published in The Rose Sheet
Executive Summary
LEE PHARMACEUTICALS FIRST QUARTER SALES DROP 29.9% to $2.4 mil. for the period ended Dec. 31 due to retailers' lower inventory levels, the company reported recently. However, Lee said, the decline "was partially offset by sales of newly acquired brands" such as ThexForte vitamins, Creo-Terpin liquid cough suppressant, Tear-Gard eye lubricant, Iodex anti-infective ointments, Dr. Hand's teething products and Dentlock denture adhesive brands, purchased from Medtech Labs last spring ("The Rose Sheet," May 24, p. 3). Lee also acquired Sundance aloe products in September and Saxon cream aftershaves in October.